We want all general practitioners to have received appropriate training, in order to provide high quality care to people with dementia, regardless of the person’s age or individual needs.

The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies who set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.

Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a Health Care Practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.

The NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to improving training for workers caring for people with dementia.

The Long Term plan also sets out the plan for there to be more healthcare staff working in and with GP practices, which will mean people will be able to get an appointment with the right professional depending on their needs. This means that those with dementia will be able to access the most appropriate support more quickly.

The plan will include more GPs, nurses and 20,000 additional pharmacists, physiotherapists, paramedics, physician associates and social prescribing link. These bigger teams of staff will work with other local services to make sure people, including those with dementia, get better access to a wider range of support for their needs.

We are seeing more people from younger cohorts with multimorbidity. Multimorbidity challenges the specialised approach to medicine, which has improved our ability to successfully treat single diseases. The Long Term Plan also addresses the increased need for medical and other clinical professionals with generalist and core skills to manage and support patients with seemingly unrelated diseases.

There are also a variety of resources available on the NHS England E-learning for Health platform, including a programme on dementia care, designed to enhance the training and education of the health and social care workforce.

Officials and I are focusing on improving rail services in the short and long term. This week, I brought together representatives from across the rail industry for a leaders in rail session to discuss how, collectively, we can make changes to deliver a better passenger experience. Longer term, we remain committed to bringing track and train back together under Great British Railways, and to continuing to build on the £100 billion of investment since 2010.

The UK National Screening Committee (UK NSC) is aware of research into the use of three-dimensional (3D) mammography and the growing interest to use artificial intelligence (AI) in the National Health Service breast screening programme. Guidance has been published on GOV.UK on the use of Tomosynthesis 3D imaging in a clinical trial setting as part of the NHS breast screening programme.

The UK NSC had also worked with Health Technology Assessments to design an evaluation of existing AI in a prospective study to look at whether it could be used to read breast screening mammograms.

There are currently no plans to adopt these technologies, but evidence to inform a UK NSC decision on the use of 3D mammography and AI in the NHS breast screening programme will be reviewed by the Committee when available.

The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 years old to 71 years old are invited for breast screening every three years. A trial, AgeX is looking at the impact of increasing or decreasing, or both, the screening age for the breast screening programme. When the results from this trial are available, the UK NSC will review the findings. The UK NSC plans to review the evidence for risk stratification in breast screening to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.

The UK National Screening Committee (UK NSC) plans to review the evidence for risk stratification in breast screening, to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.

In 2019, the UK NSC reviewed the benefit of additional screening with ultrasound after a negative mammography screening, for women with dense breasts. The Committee concluded that there was insufficient evidence to recommend additional ultrasound screening at that time.

The Breast Screening Risk Adaptive Imaging for Density trial is looking into the use of supplementary imaging techniques for women within the standard breast screening programme, who are found to have radiographically dense breast tissue. The UK NSC will review this evidence when it becomes available.

The dementia diagnosis rate is not calculated for patients aged under 65 years old. This is because the numbers of patients known to have dementia in the sample population age groups comprising the zero to 64-year-old age range, are not large enough for reliable estimates to be made. Nonetheless, NHS England is committed to delivering high quality care and support for every person with dementia at every age, and central to this is the provision of personalised care.

As part of the spending review settlement in 2021/22, £17 million was allocated to the National Health Service to address dementia waiting lists and to increase the number of diagnoses, which had been adversely impacted by the pandemic. NHS England will share reporting on the impact of this funding and examples of good practice with dementia clinical networks in March 2024.

The dementia diagnosis rate is not calculated for patients aged under 65 years old. This is because the numbers of patients known to have dementia in the sample population age groups comprising those aged between zero and 64 years old are not large enough for reliable estimates to be made.

The dementia diagnosis rate for patients aged 65 years old and over is calculated and published monthly via the Primary Care Dementia Data publication, which is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/primary-care-dementia-data

This publication does include a monthly count of the number of patients aged 65 years old and under who do have a dementia diagnosis on their patient record; this is expressed as a raw count and as a percentage of registered patients aged between zero and 64 years old.

Provision of dementia health care services is the responsibility of local integrated care boards (ICBs). NHS England would expect ICBs to commission services based on local population needs, taking account of the National Institute for Health and Care Excellence guidelines.

The Dementia Well Pathway includes diagnosing well, living/ supporting well and dying well, and highlights that services need to be integrated, commissioned, monitored, and aligned with NICE standards for each component of the pathway. It makes it clear that the needs, wishes and preferences of each individual, including those of working age, should be taken into account in planning and providing their care.

Ofgem’s new price cap means that from April, the average bill is set to drop by £238. This shows that our plan is working: we have halved inflation and energy prices are at their lowest level in two years. Alongside that, we have taken the number of homes that are well insulated up from 14% in 2010 to 50% now. We have recently set out plans to help more customers access smarter energy tariffs, which could save them up to £900 a year.

Our absolute priority is to get more police onto our streets, cut crime, protect the public and bring more criminals to justice. We are supporting the police by providing them with the resources they need. Part of this necessitates police recruitment and training. We delivered our commitment to recruit an additional 20,000 officers by March 2023 and there are over 149,000 officers England and Wales, which is higher than the previous peak in March 2010 before the Police Uplift Programme.

The Government continues to fund True Vision, an online hate crime reporting portal designed so that victims of all forms of hate crime do not have to visit a police station to report. We also fund the National Online Hate Crime Hub, a central capability designed to provide expert advice to support individual local police forces in dealing with online hate crime.

The care of and treatment for patients with cancers, including liver cancer, is a priority for the Government. National Health Service cancer standards have been reformed with the support of clinicians to speed up diagnosis for patients, which means people will receive a diagnosis or have cancer ruled out within 28 days of urgent cancer referral from their general practice. NHS England’s Early Diagnosis of Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.

The Government is taking steps through NHS England to improve outcomes for cancer patients, including liver cancer. Diagnostic checks are a key part of cancer pathways and the 153 community diagnostic centres (CDCs) opened by the Government will give earlier diagnostic tests, benefitting millions of patients including those who are referred with suspected less survivable cancers. NHS systems have been asked to prioritise CDC capacity towards their most challenged cancer pathways, where this is clinically appropriate, and these centres have delivered over six million additional tests for all elective activity since July 2021.

Science, technology, engineering and mathematics (STEM) talent and skills are a vital strand of the government’s UK Science and Technology Framework, published in 2023, which aims to cement the UK’s status as a science and technology superpower by 2030.

The department is working with the Department for Science, Innovation and Technology, including through government-industry groups such as the Digital Skills Council. This brings together government and industry to address current and future demand for digital skills, including promoting routes into digital careers and the range of opportunities to re-skill and up-skill.

The department is making it easier for people of all ages and backgrounds to access the STEM training they need through the ladder of opportunity provided by our skills system reforms, including:

• Investment of £3.8 billion over the course of this parliament to strengthen higher education (HE) and further education (FE).

• Scaling up delivery of apprenticeships, T Levels, Skills Bootcamps, and Higher Technical Qualifications, and establishing our network of 21 Institutes of Technology.

There are over 350 high-quality, employer-designed STEM apprenticeships and from 2024 students will be able to apply for apprenticeships on the UCAS website. The number of digital, ICT practitioner apprenticeship starts have increased year-on-year since 2019/20, with 24,140 starts in the 2022/23 year (over 40% increase compared to starts in the 2019/20 year).

Over 1,000 Skills Bootcamps are available across the country, offering training in tech subjects such as software development, cyber security and data analytics.

The introduction of a Lifelong Learning Entitlement will transform access to FE and HE, offering all adults the equivalent of four years’ worth of student loans to use flexibly on quality education and skills training over their lifetime.

These programmes are achieving the vision set out in the UK Science and Technology Framework to boost the supply of tech skills.

The Government regularly reviews eGate eligibility for all groups, including British Nationals (Overseas). We have set out an ambitious vision for the future border in the New Plan for Immigration and remain committed to increasing the use of automation amongst those currently eligible and exploring options to allow more cohorts to use eGates.

The National Genomic Test Directory defines which genomic tests must be delivered by the NHS Genomic Laboratory Hubs in England, as well as who is eligible for genomic testing. The directory currently covers testing for over 3,200 rare diseases and over 200 cancer clinical indications. NHS England regularly updates the directory, through a robust and evidence-based test evaluation process, to keep pace with scientific and technological advances, and to ensure that genomic testing is available for all patients for whom it would be of clinical benefit. Testing is available for all eligible patients across England.